Mark Velleca
CEO
Black Diamond TherapeuticsWashington, District of Columbia, United States
6 investmentsMark Velleca is a CEO at Black Diamond Therapeutics based in Washington, District of Columbia, United States. Mark Velleca has backed 6 companies, including iOnctura, IMMvention Therapeutix and Inc.. Investment focus areas include Health Care, Drug Discovery and Wellness.
Sign up to access email, LinkedIn & portfolio
Investment Focus
Portfolio Companies (9)
| 1 | iOnctura |
| 2 | IMMvention Therapeutix |
| 3 | Inc. |
| 4 | Myeloid Therapeutics |
| 5 | StrideBio |
| 6 | Inc |
| 7 | Gilead Sciences |
| 8 | G1 Therapeutics |
| 9 | Inc. |
Showing 1–9 of 9
Access Full Contact Information
Get Mark Velleca's email, LinkedIn, Twitter, full portfolio of investments, and export data to CSV.
Email
LinkedIn
Portfolio
3-day free trial, cancel anytime
Raising a round? Run your numbers first
Free tools founders use before pitching investors like this one.